These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Constructing a model: economic evaluations in transfusion medicine, Part 3. Kacker S; Frick KD; Tobian AA Transfusion; 2013 Sep; 53(9):1885-7. PubMed ID: 23560614 [No Abstract] [Full Text] [Related]
5. Cost-effectiveness analysis: what it really means for transfusion medicine decision making. Custer B; Hoch JS Transfus Med Rev; 2009 Jan; 23(1):1-12. PubMed ID: 19056030 [TBL] [Abstract][Full Text] [Related]
6. [Health economic effects of acquired immunologic deficiency syndrome (AIDS) in the area of blood donor services]. Beske F; Hanpft R Offentl Gesundheitswes; 1987 Feb; 49(2):99-101. PubMed ID: 2952926 [No Abstract] [Full Text] [Related]
7. [Estimating the microcosts of blood transfusion for hemato-oncological patients]. Brilhante D; Macedo A; Santos A Acta Med Port; 2008; 21(6):575-80. PubMed ID: 19331791 [TBL] [Abstract][Full Text] [Related]
8. Laboratory costs of a hospital-based blood transfusion service in Malawi. Lara AM; Kandulu J; Chisuwo L; Kashoti A; Mundy C; Bates I J Clin Pathol; 2007 Oct; 60(10):1117-20. PubMed ID: 17412875 [TBL] [Abstract][Full Text] [Related]
9. The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. Rosenshein MS; Farewell VT; Price TH; Larson EB; Dale DC N Engl J Med; 1980 May; 302(19):1058-62. PubMed ID: 6767978 [TBL] [Abstract][Full Text] [Related]
10. Reducing blood transfusion. Focus should be on improving patients' ability to make own blood. Cavill I BMJ; 2002 Sep; 325(7365):655. PubMed ID: 12269319 [No Abstract] [Full Text] [Related]
11. Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative Transfusion (ISPOT) investigators. Fergusson D; van Walraven C; Coyle D; Laupacis A Transfus Med Rev; 1999 Apr; 13(2):106-17. PubMed ID: 10218234 [No Abstract] [Full Text] [Related]
12. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610 [TBL] [Abstract][Full Text] [Related]
13. Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group. Tretiak R; Laupacis A; Rivière M; McKerracher K; Souêtre E CMAJ; 1996 May; 154(10):1501-8. PubMed ID: 8625000 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of production costs of allogenic and autologous blood preservation]. Diekamp U Beitr Infusionsther Transfusionsmed; 1994; 32():505-11. PubMed ID: 9480153 [TBL] [Abstract][Full Text] [Related]
16. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. Green WS; Toy P; Bozic KJ J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224 [TBL] [Abstract][Full Text] [Related]
17. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Blanchette CM; Wang PF; Joshi AV; Asmussen M; Saunders W; Kruse P Eur Spine J; 2007 Mar; 16(3):353-63. PubMed ID: 16463198 [TBL] [Abstract][Full Text] [Related]
18. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion. Glenngård AH; Persson U; Söderman C Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807 [TBL] [Abstract][Full Text] [Related]
19. [Cost of blood transfusion in Spain]. Darba J; Restovic G Med Clin (Barc); 2008 Jan; 130(1):37-8; author reply 38-9. PubMed ID: 18221648 [No Abstract] [Full Text] [Related]
20. Health economics of blood transfusion safety--focus on sub-Saharan Africa. van Hulst M; Smit Sibinga CT; Postma MJ Biologicals; 2010 Jan; 38(1):53-8. PubMed ID: 20022523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]